185 related articles for article (PubMed ID: 29316113)
1. Drug-induced liver injury is frequently associated with severe cutaneous adverse drug reactions: experience from two Australian tertiary hospitals.
Fang WC; Adler NR; Graudins LV; Goldblatt C; Goh MSY; Roberts SK; Trubiano JA; Aung AK
Intern Med J; 2018 May; 48(5):549-555. PubMed ID: 29316113
[TBL] [Abstract][Full Text] [Related]
2. An epidemiological and clinical analysis of cutaneous adverse drug reactions seen in a tertiary hospital in Johor, Malaysia.
Choon SE; Lai NM
Indian J Dermatol Venereol Leprol; 2012; 78(6):734-9. PubMed ID: 23075643
[TBL] [Abstract][Full Text] [Related]
3. Drug-induced liver injury associated with severe cutaneous adverse drug reactions: A nationwide study in Taiwan.
Huang YS; Wu CY; Chang TT; Peng CY; Lo GH; Hsu CW; Hu CT; Huang YH
Liver Int; 2021 Nov; 41(11):2671-2680. PubMed ID: 34153177
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of liver injury in drug-induced systemic hypersensitivity reactions.
Lee T; Lee YS; Yoon SY; Kim S; Bae YJ; Kwon HS; Cho YS; Moon HB; Kim TB
J Am Acad Dermatol; 2013 Sep; 69(3):407-15. PubMed ID: 23632341
[TBL] [Abstract][Full Text] [Related]
5. Drug-Induced liver Injury Associated with Severe Cutaneous Hypersensitivity Reactions: A Complex Entity in Need of a Multidisciplinary Approach.
Sanabria-Cabrera J; Medina-Cáliz I; Stankevičiūtė S; Rodríguez-Nicolás A; Almarza-Torres M; Lucena MI; Andrade RJ
Curr Pharm Des; 2019; 25(36):3855-3871. PubMed ID: 31696806
[TBL] [Abstract][Full Text] [Related]
6. Trends in culprit drugs and clinical entities in cutaneous adverse drug reactions: a retrospective study.
Wang F; Zhao YK; Li M; Zhu Z; Zhang X
Cutan Ocul Toxicol; 2017 Dec; 36(4):370-376. PubMed ID: 28423957
[TBL] [Abstract][Full Text] [Related]
7. Incidence of cutaneous adverse drug reactions among medical inpatients of Sultanah Aminah Hospital Johor Bahru.
Latha S; Choon SE
Med J Malaysia; 2017 Jun; 72(3):151-156. PubMed ID: 28733562
[TBL] [Abstract][Full Text] [Related]
8. Drug-induced Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS-TEN overlap: a multicentric retrospective study.
Barvaliya M; Sanmukhani J; Patel T; Paliwal N; Shah H; Tripathi C
J Postgrad Med; 2011; 57(2):115-9. PubMed ID: 21654132
[TBL] [Abstract][Full Text] [Related]
9. Drug-induced liver injury associated with Stevens-Johnson syndrome/toxic epidermal necrolysis: Patient characteristics, causes, and outcome in 36 cases.
Devarbhavi H; Raj S; Aradya VH; Rangegowda VT; Veeranna GP; Singh R; Reddy V; Patil M
Hepatology; 2016 Mar; 63(3):993-9. PubMed ID: 26439084
[TBL] [Abstract][Full Text] [Related]
10. Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study.
Chalasani N; Bonkovsky HL; Fontana R; Lee W; Stolz A; Talwalkar J; Reddy KR; Watkins PB; Navarro V; Barnhart H; Gu J; Serrano J;
Gastroenterology; 2015 Jun; 148(7):1340-52.e7. PubMed ID: 25754159
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous adverse drug reactions seen in a tertiary hospital in Johor, Malaysia.
Ding WY; Lee CK; Choon SE
Int J Dermatol; 2010 Jul; 49(7):834-41. PubMed ID: 20618508
[TBL] [Abstract][Full Text] [Related]
12. Association Between HLA-B*1301 and Dapsone-Induced Cutaneous Adverse Drug Reactions: A Systematic Review and Meta-analysis.
Tangamornsuksan W; Lohitnavy M
JAMA Dermatol; 2018 Apr; 154(4):441-446. PubMed ID: 29541744
[TBL] [Abstract][Full Text] [Related]
13. Severe Cutaneous Adverse Drug Reactions: Presentation, Risk Factors, and Management.
Mustafa SS; Ostrov D; Yerly D
Curr Allergy Asthma Rep; 2018 Mar; 18(4):26. PubMed ID: 29574562
[TBL] [Abstract][Full Text] [Related]
14. Stevens-Johnson syndrome and toxic epidermal necrolysis due to anticonvulsants share certain clinical and laboratory features with drug-induced hypersensitivity syndrome, despite differences in cutaneous presentations.
Teraki Y; Shibuya M; Izaki S
Clin Exp Dermatol; 2010 Oct; 35(7):723-8. PubMed ID: 19874350
[TBL] [Abstract][Full Text] [Related]
15. Drug-induced liver injury with skin reactions: Drugs and host risk factors, clinical phenotypes and prognosis.
Devarbhavi H; Raj S
Liver Int; 2019 May; 39(5):802-811. PubMed ID: 30515930
[TBL] [Abstract][Full Text] [Related]
16. Adverse cutaneous drug reactions among hospitalized patients: five year surveillance.
Turk BG; Gunaydin A; Ertam I; Ozturk G
Cutan Ocul Toxicol; 2013 Mar; 32(1):41-5. PubMed ID: 22812902
[TBL] [Abstract][Full Text] [Related]
17. Liver injury in patients with DRESS: A clinical study of 72 cases.
Lin IC; Yang HC; Strong C; Yang CW; Cho YT; Chen KL; Chu CY
J Am Acad Dermatol; 2015 Jun; 72(6):984-91. PubMed ID: 25801338
[TBL] [Abstract][Full Text] [Related]
18. A Comparative Analysis Between Antibiotic- and Nonantibiotic-Associated Delayed Cutaneous Adverse Drug Reactions.
Trubiano JA; Aung AK; Nguyen M; Fehily SR; Graudins L; Cleland H; Padiglione A; Peleg AY
J Allergy Clin Immunol Pract; 2016; 4(6):1187-1193. PubMed ID: 27283055
[TBL] [Abstract][Full Text] [Related]
19. Spontaneous cutaneous adverse drug reaction reports-An analysis of a 10-year dataset in Singapore.
Wong SX; Tham MY; Goh CL; Cheong HH; Chan SY
Pharmacol Res Perspect; 2019 Apr; 7(2):e00469. PubMed ID: 30911397
[TBL] [Abstract][Full Text] [Related]
20. Characterization of drug-induced liver injury associated with drug reaction with eosinophilia and systemic symptoms in two prospective DILI registries.
Medina-Cáliz I; Sanabria-Cabrera J; Villanueva-Paz M; Aukštikalnė L; Stephens C; Robles-Díaz M; Pinazo-Bandera JM; García-Cortes M; Conde I; Soriano G; Bessone F; Hernandez N; Nunes V; Paraná R; Lucena MI; Andrade RJ; Niu H; Alvarez-Alvarez I
Arch Toxicol; 2024 Jan; 98(1):303-325. PubMed ID: 38051367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
